Evidence map›Paper›PMID 36782230›Full record

ReviewBMC urology2023

A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features.

Xue Wang, Jingjing Yu, Xiaodong Fan, Suya Ma, Xiaohong Xie, Ning Gao, Shuaishuai Huang, Aimei Lu

Open access · goldAbstract readReviewCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Review in BMC urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. IJU case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Xue WangDepartment of Ultrasound, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China.
Jingjing YuDepartment of Pathology, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China.
Xiaodong FanDepartment of Urologic Surgery, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China.
Suya MaDepartment of Ultrasound, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China.
Xiaohong XieDepartment of Ultrasound, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China.
Ning GaoTumor Companion Diagnosis Broad Market Business Unit, 3D Medicines Inc., Shanghai, People's Republic of China.
Shuaishuai Huang *Department of Urologic Surgery, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China. ss.huang@aliyun.com.ORCID http://orcid.org/0000-0001-6894-2924
Aimei Lu *Department of Ultrasound, Ningbo Yinzhou Second Hospital, Ningbo, 315000, Zhejiang, People's Republic of China.
Ningbo No. 2 Hospital · CNBroadcom (Israel) · IL

Funding

General Projects of Zhejiang Medical and Health Science Plan 2021KY1067Ningbo Natural Science Foundation 2019A610263the Science and Technology Project of Yinzhou 2019AS0019
6 · The paper itself

Abstract

backgroundAlveolar soft part sarcoma (ASPS) is a rare kind of malignant soft tissue tumor with undefined differentiation, of which the incidence rate accounts for only 0.5-1.0% among all kinds of soft tissue tumors. An even rarer ASPS occurs in kidney. CASE PRESENTATION: Here we reported a case of a 7-year-old girl diagnosed with nephrogenic ASPS, regarding the analyses of the incidence, clinical manifestation, pathology and genetic diagnosis, in order to deepen the recognition of the disease.

conclusionsASPS is very rare, and tends to occur to young patients. It is very significant to precisely diagnose ASPS at an early stage, which will be the key point for the following treatment choices and prognosis.

Indexed as

Sarcoma, Alveolar Soft PartSoft Tissue NeoplasmsChildFemaleHumansIncidenceKidneyPrognosisAlveolar soft part sarcomaClinical manifestationGeneticNephrogenicTFE3

Identifiers

PMID36782230
PMCPMC9926823
OpenAlexW4320483872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.